Growth Metrics

Armata Pharmaceuticals, Inc. (ARMP) Accounts Payables (2016 - 2018)

Armata Pharmaceuticals' Accounts Payables history spans 6 years, with the latest figure at $714000.0 for Q3 2018.

  • For Q3 2018, Accounts Payables fell 24.76% year-over-year to $714000.0; the TTM value through Sep 2018 reached $714000.0, down 24.76%, while the annual FY2017 figure was $578000.0, 64.25% down from the prior year.
  • Accounts Payables for Q3 2018 was $714000.0 at Armata Pharmaceuticals, up from $682000.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $2.2 million in Q2 2016 and bottomed at $578000.0 in Q4 2017.
  • The 5-year median for Accounts Payables is $1.3 million (2014), against an average of $1.3 million.
  • The largest annual shift saw Accounts Payables surged 88.46% in 2016 before it tumbled 64.25% in 2017.
  • A 5-year view of Accounts Payables shows it stood at $1.2 million in 2014, then dropped by 1.2% to $1.2 million in 2015, then skyrocketed by 40.24% to $1.6 million in 2016, then crashed by 64.25% to $578000.0 in 2017, then rose by 23.53% to $714000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Accounts Payables are $714000.0 (Q3 2018), $682000.0 (Q2 2018), and $810000.0 (Q1 2018).